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2: Instructional procedures manual was created for 15 common
procedures and provided to clinics. Phase 3: Postintervention
survey was distributed after providers had access to procedures
manual.
Results: Presurvey data revealed the majority of respondents
felt neutral about their ability to perform procedures. However,
residents felt more comfortable performing procedures than
faculty. Postsurvey data revealed that a minority of respondents
were aware of or used the procedures manual.
Conclusion: Our study demonstrated that a targeted intervention
to improve the efficiency of procedure performance in the clinic
setting was not well utilized. Therefore, a definitive conclusion
about the ability of the intervention to improve the efficiency
of procedure performance was not able to be made. Future
areas of focus include better promotion of and ease of access
to any selected intervention to improve efficiency of procedure
performance.
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Background: Studies showed that 20% to 30% of opioid
analgesic drugs prescribed for chronic pain in the United States
are misused, while the rate of opioid addiction is approximately
10%. The study describes methods to identify high-risk behavior
and forward recommendations to decrease opioid abuse.
Purpose: To assess prevalence and correlate multiple variables
with opioid abuse and to forward appropriate recommendation
to decrease the prevalence of opioid abuse in the primary care
setting.
Methods: A prospective study was conducted at a primary
health care clinic, Aurora Sinai Medical Center (Milwaukee,
WI). Over 6 months, a total of 49 consecutive patients who
take opioids were included in the study. Screener and Opioid
Assessment for Patients with Pain-Revised (SOAPP-R), with a
cutoff score of 18 (out of 24), is used to screen abuse/aberrant
drug use. Additional variables were obtained by patient chart
review. Data analysis was done using Minitab analysis software.
Results: A total of 49 patients (23 males, 26 females) were
included in the study. Mean age of patients was 45.7 ± 7
years; 22 (44.9%) patients were on hydrocodone, 16 (32.7%)
on oxycodone, 7 (14.3%) on tramadol, 3 (6.1%) on fentanyl
patch and 1 (2%) on morphine and methadone. This means 33
(66.3%) patients were on an opioid other than oxycodone. Of
the 16 on oxycodone, 12 were male (52% of gender population)
compared to 4 female (15.4% of gender population), P=0.013.
Five (10.2%) patients had high SOAPP-R scores; 3 (13%) of
the males had a high SOAPP-R score compared to 2 (7.7%)
females. Regarding males on oxycodone, 3/12 (25%) had high
SOAPP-R scores; 1/4 (25%) females on oxycodone had a high
SOAPP-R score. As age increased, the number of male patients
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using oxycodone trended upward. Older males on oxycodone
had a higher SOAPP-R score compared to younger patients.
No patient had prescriptions by more than one prescriber; 45
(91.9%) patients had no pain contract. Urine drug screen was
done in 11 (22.5%) patients.
Conclusion: Prescription opioid drug abuse is not uncommon
in primary care clinics. Use of the SOAPP-R, along with other
appropriate patient evaluations, can help primary care providers
identify high-risk behavior and decrease opioid abuse.
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Background: Heparin-induced thrombocytopenia (HIT) and
HIT with thrombosis syndrome (HITTS) are serious conditions.
Patients are at increased risk for developing HIT/HITTS with
any exposure to heparin, even intravenous line flushes. Patients
may be exposed to heparin multiple times each day when
they have a peripherally inserted central catheter (PICC) that
is flushed and capped with heparin. At Aurora Health Care,
heparin is the standard capping solution for PICCs, but with a
recent switch to positive pressurized caps, normal saline may
be a capping option that reduces patient exposure to heparin.
Purpose: To reduce heparin exposure at a single hospital by
replacing heparin with normal saline (0.9% sodium chloride)
as the standard PICC capping solution.
Methods: We implemented an interdisciplinary pilot process
change and evaluated whether normal saline was noninferior
to heparin for maintaining PICC patency. Primary outcome
measurements of patency include alteplase use due to
occlusion. Secondary objectives were any change in invasive
line infection rates and cost comparisons. The baseline patency
rate for the hospital was derived from data extracted through a
retrospective chart review from October 2013 through October
2014.
Results: Our baseline patency rate was 65.42% (N=3,095);
33% of all PICC lines placed during the 12-month period
were treated with alteplase. Patency rates during our pilot
period were based on retrospective chart reviews of patients
with PICC lines placed from February to May 2015. During
this period, a total of 979 PICC lines were evaluated. Of these,
30.4% were treated with alteplase. This resulted in a pilot
patency rate of 69.5%, which is 4.1% greater than our baseline
patency rate. Given the prespecified noninferiority margin of
5%, our pilot demonstrates that normal saline is noninferior
to heparin for maintaining PICC line patency when used
with positive pressurized caps (α<0.05). Although number of
infections increased 16%, only 9% with line infections were
part of our pilot. The estimated yearly cost of both capping
solutions is equal, at approximately $3,960 per our baseline
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